Enhanced interpretation of newborn screening results without analyte cutoff values
Gregg Marquardt(Mayo Clinic), Vagelis Papakonstantinou(Vrije Universiteit Brussel), Emily H. Smith(Mayo Clinic), Petr Horník(Charles University), Sandrine Marie(Cliniques Universitaires Saint-Luc), Robert J. Currier(California Department of Public Health), Alejandra Reuben(Hospital Nacional de Niños), David Cheillan(Centre National de la Recherche Scientifique), Kimiyo Raymond(Mayo Clinic in Arizona), Jonessy Quesada(Hospital Nacional de Niños), Khalid Al‐Thihli(Sultan Qaboos University Hospital), Adrienne Manning(Connecticut Department of Public Health), David Ludvigson(Georgia Department of Public Health), Graham Sinclair, Dimitar Gavrilov, Devin Oglesbee(Mayo Clinic in Arizona), Dietrich Matern(Mayo Clinic), Bonifacio Dy(AdventHealth Orlando), Veronica Wiley(Children's Hospital at Westmead), Yuri Cleverthon Sica, Silvia Tortorelli, Jasmin Torres(AdventHealth Orlando), Cory Porter(Colorado Department of Public Health and Environment), David McHugh(Mayo Clinic), Sahar Sharaf(Cairo University), Fred Lorey(Illinois Department of Public Health), Iman Mandour(Cairo University), Mark J Magera(Mayo Clinic), Bridget Wilcken(Children's Hospital at Westmead), Christine Vianey‐Saban(Hospices Civils de Lyon), Margretta R. Seashore(Yale University), Yannis Dotsikas(National and Kapodistrian University of Athens), Piero Rinaldo(WinnMed), Barry Lewis(Princess Margaret Hospital for Children), Petr Chrastina(Charles University), Adrya Stembridge(Emory University), Olaf A. Bodamer(Broad Institute), Mouseline Torquado Domingos, Mark Dymerski(Colorado Department of Public Health and Environment), Roland Schoos(Centre Hospitalier Universitaire de Liège), Lawrence Greed(Princess Margaret Hospital for Children), Pranesh Chakraborty(University of Ottawa), François Boemer(University of Liège), Marie‐Françoise Vincent(Cliniques Universitaires Saint-Luc), Roberto Zori(University of Florida), Osama Y. Al-Dirbashi(United Arab Emirates University), Jim Bonham(Sheffield Children's NHS Foundation Trust), Yannis L. Loukas(Athens State University), Melanie Downing(Sheffield Children's NHS Foundation Trust), Coleman Turgeon(Mayo Clinic)
Cited by 123
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326
Mutations in <i>BCKD-kinase</i> Lead to a Potentially Treatable Form of Autism with Epilepsy
|Science|2012|315
Multiple Phenotypes in Phosphoglucomutase 1 Deficiency
|New England Journal of Medicine|2014|287